Skip to search boxSkip to navigationSkip to main content

In vivo brain electrophoresis-a novel method for chemotherapy of CNS diseases

  • Mario Ammirati(corresponding author)
    ,
  • Tariq Lamki
    ,
  • Girish Chitnis
    ,
  • Xiangyu Yang
    ,
  • Duncan Russell
    ,
  • Dondrae Coble
*Corresponding author for this work
  • Ohio State University
    ,
  • Purdue University
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Abstract

Objective: The blood-brain barrier (BBB) is a protective mechanism that does its job superbly. So much so, that hitherto, brain chemotherapy has been limited by it. In fact, very few agents are effective against brain disease due to the inherent difficulties of penetrating the BBB. We describe a novel, extremely focused method for delivering drugs to specific diseased areas. This innovative method directly delivers putative substances to the pathological area, bypassing the BBB. Treatment of brain diseases could be improved by targeted, controlled delivery of therapeutic substances to diseased cerebral areas. Our described novel method-in vivo electrophoresis-achieves this.Methods: This technique was evaluated in beagles after craniotomy was performed and a custom-designed plate with electrodes inserted. The delivery of charged substances to selected areas with predictably guided movement was achieved via a created electrical field. Gadolinium, a compound unable to cross the BBB, was injected intracerebrally whereas an electrical field was created using the implanted electrodes surrounding the injection area. The electrical field-guided Gadolinium movement was evaluated using MRI.Results: Gadolinium was moved predictably using the created electrical field without complications.Conclusions: The experiment successfully demonstrated controlled movement of the substance. This technique can significantly change treatment of brain diseases because substances: i) may be moved in a controlled, predictable way-exponentially increasing therapeutic interactions with the target; and ii) no longer need to conform to constraints dictated by the BBB (molecular mass < 500 d; lipophilic), thereby increasing potential number of usable substances.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 727-734 (8 pages)

Journal (Volume, Issue Number)

Expert Opinion on Drug Delivery (Volume 12, Issue 5)

Publication milestones

  • Published - 05/01/2015

Publication status

Published - 05/01/2015

ISSN

1742-5247

Publication IDs

  • Scopus: 84928334453
  • PubMed: 25666687

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.10
Fractional count
9
Fractional count
0.90
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
12
Citation count
2

Funding Details

Four healthy female adult beagle dogs with an average weight of 7.8 kg were used for this study. This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. Animal experiments were reviewed and approved by The Ohio State University Institutional Animal Care and Use Committee (Protocol - 2013A00000001). All surgery was performed under appropriate anesthesia (see below), and all efforts were made to minimize suffering.
FunderFunding numbers
National Institutes of Health
-